BG27554A3 - Method of obtaining of derivatives of 2- aroyl- 3- phenyl- bewzothiophenes - Google Patents

Method of obtaining of derivatives of 2- aroyl- 3- phenyl- bewzothiophenes

Info

Publication number
BG27554A3
BG27554A3 BG7634551A BG3455176A BG27554A3 BG 27554 A3 BG27554 A3 BG 27554A3 BG 7634551 A BG7634551 A BG 7634551A BG 3455176 A BG3455176 A BG 3455176A BG 27554 A3 BG27554 A3 BG 27554A3
Authority
BG
Bulgaria
Prior art keywords
bewzothiophenes
aroyl
phenyl
derivatives
obtaining
Prior art date
Application number
BG7634551A
Other languages
Bulgarian (bg)
English (en)
Inventor
Chareles D Jones
Tulio Suarez
Original Assignee
Eli Lilly And Co.,Us
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Co.,Us filed Critical Eli Lilly And Co.,Us
Publication of BG27554A3 publication Critical patent/BG27554A3/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/53771,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/004Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with organometalhalides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/84Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/56Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D333/70Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BG7634551A 1975-10-28 1976-10-28 Method of obtaining of derivatives of 2- aroyl- 3- phenyl- bewzothiophenes BG27554A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62600975A 1975-10-28 1975-10-28

Publications (1)

Publication Number Publication Date
BG27554A3 true BG27554A3 (en) 1979-11-12

Family

ID=24508577

Family Applications (1)

Application Number Title Priority Date Filing Date
BG7634551A BG27554A3 (en) 1975-10-28 1976-10-28 Method of obtaining of derivatives of 2- aroyl- 3- phenyl- bewzothiophenes

Country Status (27)

Country Link
US (1) US4075227A (da)
JP (1) JPS5253852A (da)
AR (1) AR216451A1 (da)
AT (1) AT352709B (da)
AU (1) AU509682B2 (da)
BE (1) BE847718A (da)
BG (1) BG27554A3 (da)
CA (1) CA1064031A (da)
CH (1) CH626360A5 (da)
CS (1) CS196328B2 (da)
DD (1) DD127463A5 (da)
DE (1) DE2647864C2 (da)
DK (1) DK484576A (da)
ES (1) ES452737A1 (da)
FR (1) FR2329270A1 (da)
GB (1) GB1572506A (da)
GR (1) GR62400B (da)
IE (1) IE43970B1 (da)
IL (1) IL50413A (da)
MX (1) MX3972E (da)
NL (1) NL7611972A (da)
NZ (1) NZ182428A (da)
PL (1) PL109366B1 (da)
PT (1) PT65753B (da)
RO (1) RO70768A (da)
SE (1) SE427035B (da)
ZA (1) ZA766442B (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5740478A (en) * 1980-08-22 1982-03-06 Ono Pharmaceut Co Ltd Rhodanine derivative, its preparation and aldose reductase inhibitor containing rhodanine derivative
US4436748A (en) 1980-10-20 1984-03-13 Hoechst-Roussel Pharmaceuticals Inc. Benzo[b]thiophenes
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
US4528399A (en) * 1981-04-22 1985-07-09 Hoechst-Roussel Pharmaceuticals Inc. Benzo[b]thiophenes intermediates
US5354861A (en) * 1992-11-04 1994-10-11 National University Of Singapore 2-(benzyl)-3-arylbenzofurans as antitumour and hypocholesterolemic agents
IL109990A (en) * 1993-06-21 1999-06-20 Lilly Co Eli Materials and methods for screening anti-osteoporosis agents
US5523416A (en) * 1994-07-22 1996-06-04 Eli Lilly And Company Process for preparing 3-(4-aminoethoxy-benzoyl) benzo (B)-thiophenes
US5552401A (en) * 1995-02-28 1996-09-03 Eli Lilly And Company 2-benzyl-3-arylbenzothiophenes
ZA9710262B (en) * 1996-11-19 1999-05-13 Lilly Co Eli Process for the synthesis of benzothiophenes
US5908859A (en) * 1997-08-11 1999-06-01 Eli Lilly And Company Benzothiophenes for inhibiting hyperlipidemia
US6107346A (en) * 1997-08-11 2000-08-22 Eli Lilly And Company Methods for treating hyperlipidemia
US7091199B1 (en) 1999-09-14 2006-08-15 Aventis Pharmaceuticals Inc. Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 antagonists
US7125903B1 (en) 1999-09-14 2006-10-24 Aventis Pharmaceuticals Inc. Thienoisoxazolyl-and thienylpyrrazolyl-phenoxy substituted propyl derivatives useful as D4 antagonists
US7253165B2 (en) * 1999-09-14 2007-08-07 Aventis Pharmaceuticals Inc. Benzisoxazolyl-, pyridoisoxazolyl-and benzthienyl-phenoxy derivatives useful as D4 antagonists
ES2398986T3 (es) * 1999-10-04 2013-03-25 Nippon Soda Co., Ltd. Compuestos fenólicos y materiales de registro que los contienen
AU2002230409A1 (en) * 2000-11-27 2002-06-03 Eli Lilly And Company Process for preparing 3-aryl-benzo(b)thiophenes
AUPR283801A0 (en) * 2001-02-01 2001-03-01 Australian National University, The Chemical compounds and methods
JP3904517B2 (ja) * 2001-04-04 2007-04-11 日本曹達株式会社 組成物、記録材料及び記録シート
DE60202954T2 (de) * 2001-05-22 2006-01-05 Eli Lilly And Co., Indianapolis Tetrahydrochinolin-derivate zur behandlung von krankheiten ausgelöst durch zu hohem oder zu niedrigem oestrogenspiegel
DE60210283T2 (de) * 2001-05-22 2006-11-09 Eli Lilly And Co., Indianapolis 2-substituierte 1,2,3,4-tetrahydrochinoline und derivate davon, zusammensetzungen und verfahren
DE10309645A1 (de) 2003-03-06 2004-09-16 Basf Ag Verfahren zur Herstellung von a-(3-Arylthio)-acetophenonen
CN110461853A (zh) 2017-02-10 2019-11-15 G1治疗公司 苯并噻吩雌激素受体调节剂

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1456323A (en) * 1974-06-06 1976-11-24 Labaz Benzothiophenes process for preparing them and pharmaceutical compositions containing the same
US3947470A (en) * 1974-06-20 1976-03-30 Smithkline Corporation Substituted benzofurans and benzothiophenes
US4001426A (en) * 1974-10-17 1977-01-04 Smithkline Corporation Substituted benzofurans and benzothiophenes
US3983245A (en) * 1975-02-06 1976-09-28 Smithkline Corporation Certain 4-(3-azacycloalkoxy or azacycloalkylmethoxy)benzoylbenzofurans or benzothiophenes

Also Published As

Publication number Publication date
SE427035B (sv) 1983-02-28
NZ182428A (en) 1978-11-13
CS196328B2 (en) 1980-03-31
DE2647864C2 (de) 1985-04-25
CA1064031A (en) 1979-10-09
DE2647864A1 (de) 1977-05-12
JPS61344B2 (da) 1986-01-08
IE43970L (en) 1977-04-28
AT352709B (de) 1979-10-10
IL50413A0 (en) 1976-11-30
IE43970B1 (en) 1981-07-15
ATA800776A (de) 1979-03-15
ES452737A1 (es) 1978-01-01
NL7611972A (nl) 1977-05-02
AU509682B2 (en) 1980-05-22
SE7611954L (sv) 1977-04-29
AR216451A1 (es) 1979-12-28
ZA766442B (en) 1978-06-28
IL50413A (en) 1980-05-30
JPS5253852A (en) 1977-04-30
DD127463A5 (da) 1977-09-28
RO70768A (ro) 1982-10-26
BE847718A (fr) 1977-04-28
DK484576A (da) 1977-04-29
PT65753B (en) 1978-04-20
GR62400B (en) 1979-04-10
PT65753A (en) 1976-11-01
GB1572506A (en) 1980-07-30
AU1740876A (en) 1978-03-09
PL109366B1 (en) 1980-05-31
CH626360A5 (da) 1981-11-13
FR2329270A1 (fr) 1977-05-27
US4075227A (en) 1978-02-21
MX3972E (es) 1981-10-20
FR2329270B1 (da) 1979-07-27

Similar Documents

Publication Publication Date Title
BG24673A3 (en) Method of obtaining quinazone derivatives
BG27553A3 (en) Method of obtaining of 2- phenyl- 3- aroylxenzothiophenes
BG27557A4 (en) Method of obtaining of cephemic compounds
BG27554A3 (en) Method of obtaining of derivatives of 2- aroyl- 3- phenyl- bewzothiophenes
BG27548A3 (en) Method of obtaining of carbonylsubstituated 1- sulphanylbenzimidazoles
BG25071A3 (en) A method of obtaining salicileanyl derivatives
BG27370A3 (en) Method of obtaining of heterogeneous derivatives
BG27538A3 (en) Method of obtaining of n- alkyl diphenilamins derivatives
BG27542A3 (en) Method of obtaining of 1- benzazolylalkyl- 4- substituated
BG24799A3 (en) Method of obtaining benzoylureidediphenyl-esters
BG27355A3 (en) Method of obtaining of 11- desoxy- 16- ariloxy- w- tetranoprostaglandines
BG27539A3 (en) Method of obtaining of alanine derivatives
BG31070A3 (en) Method for obtaining of 11- dexoxy- 16- aryl- w- tetranoprostagine
BG30778A3 (en) Method for obtaining of eburnamenine derivatives
BG27359A3 (en) Method of obtaining acylamine derivatives
BG27899A3 (en) Method of obtaining of highdispersed cianurchloride
BG27543A3 (en) Method of obtaining of n- aryl- n- (1- l- 4- piperidinyj)- arylacetamides
BG24801A3 (en) Method of obtaining l-pyroglutamyl-l-prolineamide
JPS5280397A (en) Popymerization method of epsilonncaprolactam
CS194236B2 (en) Method of preparing derivatives of 4-oxo-hexahydro-4h-pyrazino-isoquinoline
BG27732A3 (en) Method of obtaining of di- substituated phenolethers of 3- amino- 2-hydroxipropane
BG32846A3 (en) Method for obtaining of n- methylcarbamide
BG27555A3 (en) Method of obtaining of derivatives of aroyl- phenilnaphtalenes
JPS51115485A (en) Preparation method of quinoxalineedioxide derivatives
BG28057A4 (en) Method of obtaining of 3- hydroxy- methylenchromanones